New Haven Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease
- First Posted Date
- 2015-02-25
- Last Posted Date
- 2015-08-06
- Lead Sponsor
- New Haven Pharmaceuticals, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT02370680
- Locations
- 🇺🇸
Platelet and Thrombosis Research, LLC, Baltimore, Maryland, United States
News
No news found